Our Team
Umer Raffat
Umer Raffat is a senior managing director at Evercore ISI and heads the large-cap therapeutics effort spanning major pharmaceuticals and specialty pharmaceuticals.
As of 2024, Mr. Raffat has been ranked No. 1 on 22 separate occasions by Institutional Investor (now Extel), starting from his first year covering the sector. He is top ranked across all categories he covers: biotech, pharmaceuticals and specialty pharma.
He started his equity research career under Dr. Mark Schoenebaum at Deutsche Bank in 2010, and they moved together to Evercore ISI.
In 2020, Mr. Raffat was inducted into Institutional Investor’s All-America Research Team Hall of Fame, a designation for analysts who have earned a No. 1 ranking on at least 10 occasions.
Mr. Raffat has an undergraduate degree in biology from University of Texas at Arlington and a master’s from Harvard School of Public Health.